Biomerieux SA (BIOX)

Paris
Currency in EUR
114.00
-1.50(-1.30%)
Closed
BIOX Scorecard
Full Analysis
Trading at a high earnings multiple
Fair Value
Day's Range
114.00115.80
52 wk Range
88.25117.60
Key Statistics
Edit
Prev. Close
114
Open
115.8
Day's Range
114-115.8
52 wk Range
88.25-117.6
Volume
85.51K
Average Vol. (3m)
95.27K
1-Year Change
9.83%
Book Value / Share
32.73
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
121.73
Upside
+6.78%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

Biomerieux SA Company Profile

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated Identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST Gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDASB·R·A·H·M·S PCTTM, a specific marker of severe bacterial infections/sepsis. It also provides Biomérieux vision suite, a software that provides actionable information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE Monoplex PCR tests; NUCLISENS ranges, a product for automation of the molecular biology laboratory and extraction; EMAG system For DNA and RNA extraction; ESTREAM, an automated preparation station for samples to process PCR tests; GENE-UP and VERIFLOW ranges for detection of microorganisms for the food industry. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Employees
13696
Market
France

Compare BIOX to Peers and Sector

Metrics to compare
BIOX
Peers
Sector
Relationship
P/E Ratio
32.7x4.5x−0.7x
PEG Ratio
4.86−0.040.00
Price / Book
3.5x1.7x2.6x
Price / LTM Sales
3.5x2.1x3.1x
Upside (Analyst Target)
12.8%12.7%49.4%
Fair Value Upside
Unlock8.0%8.9%Unlock

Analyst Ratings

11 Buy
3 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 121.73
(+6.78% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.49
Dividend Yield
0.74%
Industry Median 1.57%
Annualized Payout
0.85
Paid annually
5-Years Growth
+19.42%
Growth Streak

Earnings

Latest Release
Oct 30, 2024
EPS / Forecast
-- / --
Revenue / Forecast
968.70M / 958.57M
EPS Revisions
Last 90 days

People Also Watch

96.05
NEXS
+1.32%
16.10
COFA
0.00%
101.15
TEPRF
+0.35%
5.86
BOLL
+0.34%
26.28
SCOR
+0.84%

FAQ

What Is the Biomerieux (BIOX) Stock Price Today?

The Biomerieux stock price today is 114.00

What Stock Exchange Does Biomerieux Trade On?

Biomerieux is listed and trades on the Paris stock exchange.

What Is the Stock Symbol for Biomerieux?

The stock symbol for Biomerieux is "BIOX."

Does Biomerieux Pay Dividends? What’s The Current Dividend Yield?

The Biomerieux dividend yield is 0.74%.

What Is the Biomerieux Market Cap?

As of today, Biomerieux market cap is 13.46B.

What is Biomerieux Earnings Per Share?

The Biomerieux EPS is 3.49.

What Is the Next Biomerieux Earnings Date?

Biomerieux will release its next earnings report on Mar 07, 2025.

From a Technical Analysis Perspective, Is BIOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.